Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4573417019 | Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4573418012 | Product containing precisely hydralazine hydrochloride 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5278671000052118 | hydralazinhydroklorid 37,5 mg och isosorbiddinitrat 20 mg, oral tablett | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has basis of strength substance (attribute) | Isosorbide dinitrate (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Is a | Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has precise active ingredient | Hydralazine hydrochloride | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has basis of strength substance (attribute) | Hydralazine hydrochloride | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has precise active ingredient | Isosorbide dinitrate (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets